NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression
Go back to NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression| (NASDAQ: ELAB) | Delayed: 4.71 -0.14 (2.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.85 | 52 Week High | $ | |||
| Open | $4.80 | 52 Week Low | $ | |||
| Day High | $4.89 | P/E | N/A | |||
| Day Low | $4.61 | EPS | $ | |||
| Volume | 24,677 | |||||

